Citadel Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Sell |
3,899,011
-8,876
| -0.2% | -$33.1K | ﹤0.01% | 1150 |
|
|
2025
Q1 | $10.8M | Buy |
3,907,887
+640,108
| +20% | +$1.77M | ﹤0.01% | 1204 |
|
|
2024
Q4 | $18.1M | Sell |
3,267,779
-405,447
| -11% | -$2.25M | ﹤0.01% | 981 |
|
|
2024
Q3 | $30.6M | Buy |
3,673,226
+2,213,276
| +152% | +$18.5M | 0.01% | 681 |
|
|
2024
Q2 | $9.94M | Sell |
1,459,950
-1,505,636
| -51% | -$10.3M | ﹤0.01% | 1219 |
|
|
2024
Q1 | $19.5M | Buy |
2,965,586
+2,930,946
| +8,461% | +$19.2M | ﹤0.01% | 905 |
|
|
2023
Q4 | $225K | Sell |
34,640
-41,102
| -54% | -$267K | ﹤0.01% | 4486 |
|
|
2023
Q3 | $381K | Buy |
75,742
+74,286
| +5,102% | +$374K | ﹤0.01% | 4038 |
|
|
2023
Q2 | $12.7K | Sell |
1,456
-390,609
| -100% | -$3.42M | ﹤0.01% | 5339 |
|
|
2023
Q1 | $4.64M | Sell |
392,065
-123,732
| -24% | -$1.46M | ﹤0.01% | 1874 |
|
|
2022
Q4 | $5.25M | Buy |
+515,797
| New | +$5.25M | ﹤0.01% | 1749 |
|
|
2022
Q3 | – | Sell |
-38,810
| Closed | -$96K | – | 6692 |
|
|
2022
Q2 | $96K | Buy |
+38,810
| New | +$96K | ﹤0.01% | 5306 |
|
|
2021
Q3 | – | Sell |
-18,200
| Closed | -$223K | – | 7069 |
|
|
2021
Q2 | $223K | Sell |
18,200
-14,421
| -44% | -$177K | ﹤0.01% | 5469 |
|
|
2021
Q1 | $718K | Buy |
+32,621
| New | +$718K | ﹤0.01% | 4250 |
|